The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow-up of exceptional responders on the phase II trial of weekly bortezomib and rituximab in untreated and relapsed patients with waldenstrom's macroglobulinemia.
 
Joseph M. Cappuccio
No Relationships to Disclose
 
Irene M. Ghobrial
Honoraria - Bristol-Myers Squibb; Celgene; Millennium
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Onyx
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Millennium; Novartis; Onyx
 
Jorge J. Castillo
Consulting or Advisory Role - Otsuka
Research Funding - Gilead Sciences; Millennium; Pharmacyclics
 
Steven P. Treon
Consulting or Advisory Role - Janssen; Pharmacyclics
Research Funding - Janssen; Pharmacyclics
Other Relationship - Janssen; Pharmacyclics
 
Jeffrey Matous
Consulting or Advisory Role - Celgene; Millennium
Speakers' Bureau - Celgene; Millennium; Onyx; Seagen
Research Funding - Celgene (Inst); Seagen (Inst)
 
Patrick M. Henrick
No Relationships to Disclose
 
Aaron M. Caola
No Relationships to Disclose
 
Emily Lai
No Relationships to Disclose